CRESEMBA
Identification of Cresemba
| No description |
Google image searchProduct monograph
Active ingredient
isavuconazole (isavuconazonium sulfate), 100 MG
DIN: 02483971
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: AVIR PHARMA INC.
Date: 02-MAY-2019
ATC:
- J02 — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J02A — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- J02AC — Triazole derivatives (ATC, ATC/DDD)
- J02AC05 — ISAVUCONAZOLE (ATC/DDD)
Reference brand drug: Cresemba
